The asthma management gap - why current treatment strategies can fail to provide optimal asthma control

被引:5
作者
Fabbri, LM
Boulet, LP
Kardos, P [1 ]
Vogelmeier, C
机构
[1] Klin Maingau, Gemeinschaftspraxis & Pneumol Allergol Zentrum &, D-60318 Frankfurt, Germany
[2] Univ Modena & Reggio Emilia, Dept Resp Dis, Modena, Italy
[3] Univ Laval, Inst Cardiol & Pneumol, Ste Foy, PQ G1K 7P4, Canada
[4] Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany
关键词
adjustable maintenance dosing; asthma; asthma control; budesonide/formoterol; treatment guidelines;
D O I
10.1111/j.1368-504X.2004.00259.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Standard asthma management strategies are not always successful at providing optimal control. Despite the availability of effective asthma drugs and the publication of numerous asthma management guidelines, many patients are not adequately controlled and experience frequent asthma symptoms and exacerbations. Current guidelines advocate a stepwise approach to treatment, initially through inhaled corticosteroids, with the addition of a long-acting beta(2)-agonist or another asthma medication when required. Once asthma control has been achieved with an appropriate starting dose, corticosteroids should be reduced to the lowest effective dose with the option to step up during periods of asthma worsening. Such strategies require personalised, written action plans to enable patients to make appropriate changes in medication with less requirement for intervention by the physician. Adjustable maintenance dosing with budesonicle/formoterol in a single inhaler offers an effective means to adapt the medication to the needs of the patient, as indicated in the current guidelines.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 70 条
[1]
Andersson FL, 2001, J ALLERGY CLIN IMMUN, V107, pS245
[2]
*ASS ASTHM ALL, OCC ASTHM DICT ALL
[3]
The costs of asthma [J].
Barnes, PJ ;
Jonsson, B ;
Klim, JB .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (04) :636-642
[4]
Overcoming barriers to nonadherence in asthma treatment [J].
Bender, BG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (06) :S554-S559
[5]
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial [J].
Bjermer, L ;
Bisgaard, H ;
Bousquet, J ;
Fabbri, LM ;
Greening, AP ;
Haahtela, T ;
Holgate, ST ;
Picado, C ;
Menten, J ;
Dass, SB ;
Leff, JA ;
Polos, PG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7420) :891-895
[6]
Goals of asthma management - A step-care approach [J].
Bone, RC .
CHEST, 1996, 109 (04) :1056-1065
[7]
Boulet Louis-Philippe, 2002, Can Respir J, V9, P417
[9]
Boulet LP, 1999, CAN MED ASSOC J, V161, pS1
[10]
Boulet LP, 2001, CAN RESP J SA, V8, P5